Stay updated on FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial

Sign up to get notified when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with a reference to the Contacts and Locations section.
    Difference
    2%
    Check dated 2024-12-07T16:10:16.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The website has added new features while removing extensive options for downloading study data, including various file formats and detailed data fields.
    Difference
    3%
    Check dated 2024-11-23T04:35:50.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Several key medical and research resources related to soft tissue sarcoma and treatments like Trabectedin, Ipilimumab, and Nivolumab have been removed from the website.
    Difference
    0.5%
    Check dated 2024-11-15T23:42:35.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, with new resources added including links to MedlinePlus, DailyMed, and PubMed, as well as additional data fields for study information.
    Difference
    4%
    Check dated 2024-11-08T18:18:32.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T10:40:45.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.
    Difference
    0.1%
    Check dated 2024-10-25T00:38:00.000Z thumbnail image

Stay in the know with updates to FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FirstLine Trabectedin, Ipilimumab, Nivolumab Clinical Trial page.